|
Article Cited by others ORIGINAL ARTICLE
Gemcitabine and treatment of diffuse large B-cell lymphoma in relapsed or refractory elderly patients: A prospective randomized trial in Algeria
Aribi Mourad, Mesli Naima, Remla Nesrine, Sari Badr-Eddine, Taleb Abdesselam, Touhami Hadj, Bekadja Mohamed-Amine, Zouaoui-Benhadji Zahia, Bouzid Kamel, Meguenni Kaoual
Year : 2010| Volume: 6| Issue : 1 | Page no: 41-46 | This article has been cited by | | 1 |
Survivin as prognostic and predictive factor in patients treated with gemcitabine, dexamethasone, and cisplatin for relapsed or refractory aggressive NHL |
|
| | Lamiss Mohamed Abd el Aziz | | | Medical Oncology. 2014; 31(11) | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Phase I/II trial of vorinostat with rituximab, cyclophosphamide, etoposide and prednisone as palliative treatment for elderly patients with relapsed or refractory diffuse large B-cell lymphoma not eligible for autologous stem cell transplantation |
|
| | David J. Straus,Paul A. Hamlin,Matthew J. Matasar,Maria Lia Palomba,Pamela R. Drullinsky,Andrew D. Zelenetz,John F. Gerecitano,Ariela Noy,Audrey M. Hamilton,Rebecca Elstrom,Brett Wegner,Katy Wortman,David Cella | | | British Journal of Haematology. 2014; : n/a | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Clinical Efficacy and Safety in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Systematic Literature Review |
|
| | Ann Colosia,Annete Njue,Peter C. Trask,Robert Olivares,Shahnaz Khan,Adeline Abbe,Rachel Police,Jianmin Wang,Rodrigo Ruiz-Soto,James A. Kaye,Farrukh Awan | | | Clinical Lymphoma Myeloma and Leukemia. 2014; | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
GDP regimen as salvage treatment for relapsed refractory non-Hodgkinæ s lymphoma |
|
| | Zhao, J. and Feng, K.-C. and Zhao, Z.-Q. and Su, L.-P. and Wang, J. and Ma, L. and He, J.-X. and Wang, L.-Y. and Li, X. and Wang, Y.-L. and Han, W.-E. and Zheng, Y.-P. | | | Journal of Leukemia and Lymphoma. 2012; 21(8): 472-474 | | | [Pubmed] [Google Scholar] | | | 5 |
Synergistic cytotoxicity of the DNA alkylating agent busulfan, nucleoside analogs and suberoylanilide hydroxamic acid in lymphoma cell lines |
|
| | Benigno C. Valdez,David Murray,Yago Nieto,Yang Li,Guiyun Wang,Richard E. Champlin,Borje S. Andersson | | | Leukemia & Lymphoma. 2012; 53(5): 973 | | | [Pubmed] [Google Scholar] [DOI] | | | 6 |
Synergistic cytotoxicity of the DNA alkylating agent busulfan, nucleoside analogs and suberoylanilide hydroxamic acid in lymphoma cell lines |
|
| | Valdez, B.C., Murray, D., Nieto, Y., Li, Y., Wang, G., Champlin, R.E., Andersson, B.S. | | | Leukemia and Lymphoma. 2012; 53(5): 973-981 | | | [Pubmed] [Google Scholar] | |
|
|
|
|
